SAGE Therapeutics’s Novel Approach To Treatment Of CNS Disorders To Be Highlighted At Leading Industry And Scientific Conferences

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CAMBRIDGE, Mass.--(BUSINESS WIRE)--SAGE Therapeutics, a biopharmaceutical company developing novel medicines to treat central nervous system (CNS) diseases, today announced the company’s pipeline programs and science behind its novel therapeutic product engine will be highlighted at three key upcoming conferences.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC